These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16930922)

  • 21. [Review of a technic for the estimation of area under the concentration curve in pharmacokinetic analysis].
    Bourget P; Delouis JM
    Therapie; 1993; 48(1):1-5. PubMed ID: 8356539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
    Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
    J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics I: background, concepts, and models.
    Ette EI; Williams PJ
    Ann Pharmacother; 2004 Oct; 38(10):1702-6. PubMed ID: 15328391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods.
    Sheiner LB
    Drug Metab Rev; 1984; 15(1-2):153-71. PubMed ID: 6745080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel.
    Yousef AM; Arafat T; Bulatova NR; Al-Zumyli R
    J Clin Pharm Ther; 2008 Aug; 33(4):439-49. PubMed ID: 18613862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of different approaches to predict metabolic drug-drug interactions.
    Einolf HJ
    Xenobiotica; 2007; 37(10-11):1257-94. PubMed ID: 17968745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints.
    Ambrose PG; Meagher AK; Passarell JA; Van Wart SA; Cirincione BB; Rubino CM; Korth-Bradley JM; Babinchak T; Ellis-Grosse E
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):38-42. PubMed ID: 19073300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.
    Plock N; Buerger C; Joukhadar C; Kljucar S; Kloft C
    Drug Metab Dispos; 2007 Oct; 35(10):1816-23. PubMed ID: 17639029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A random sampling approach for robust estimation of tissue-to-plasma ratio from extremely sparse data.
    Chu HM; Ette EI
    AAPS J; 2005 Sep; 7(1):E249-58. PubMed ID: 16146346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human.
    Lombardo F; Obach RS; Dicapua FM; Bakken GA; Lu J; Potter DM; Gao F; Miller MD; Zhang Y
    J Med Chem; 2006 Apr; 49(7):2262-7. PubMed ID: 16570922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of milk/plasma concentration ratio of drugs.
    Larsen LA; Ito S; Koren G
    Ann Pharmacother; 2003 Sep; 37(9):1299-306. PubMed ID: 12921514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reported anatomical variability naturally leads to multimodal distributions of Denavit-Hartenberg parameters for the human thumb.
    Santos VJ; Valero-Cuevas FJ
    IEEE Trans Biomed Eng; 2006 Feb; 53(2):155-63. PubMed ID: 16485744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I).
    Veng-Pedersen P
    Clin Pharmacokinet; 1989 Nov; 17(5):345-66. PubMed ID: 2684472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of different partial AUCs as indirect measures of rate of drug absorption in comparative pharmacokinetic studies.
    Duquesnoy C; Lacey LF; Keene ON; Bye A
    Eur J Pharm Sci; 1998 Oct; 6(4):259-64. PubMed ID: 9795077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The trigonometric responder approach: a new method for detecting responders to pharmacological or experimental challenges.
    Reuter M; Siegmund A; Netter P
    Pharmacopsychiatry; 2002 Sep; 35(5):182-9. PubMed ID: 12237789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.